...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and in vitro microbiological evaluation of an array of biolabile 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides.
【24h】

Synthesis and in vitro microbiological evaluation of an array of biolabile 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides.

机译:一系列生物不稳定性2-吗啉代-N-(4,6-二芳基嘧啶-2-基)乙酰胺的合成及体外微生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Biolabile 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42 have been synthesized and evaluated for their in vitro antibacterial and antifungal activities. The minimum inhibitory concentration tested for the same compounds against the same set of bacterial and fungal strains shows that the compounds 36 and 38 against beta-Heamolytic streptococcus and Klebsiella pneumonia, 40 against Escherichia coli and Pseudomonas, have excellent antibacterial activity. Compounds 36, 38 and 42 show inhibition against Aspergillus flavus, compound 41 against Microsporum gypsuem, 42 against Mucor, and compounds 39 and 40 against Rhizopus.
机译:已经合成了生物不稳定性2-吗啉代-N-(4,6-二芳基嘧啶-2-基)乙酰胺34-42,并对其体外抗菌和抗真菌活性进行了评估。对相同化合物对同一组细菌和真菌菌株的最低抑菌浓度测试表明,化合物36和38对β-溶血性链球菌和肺炎克雷伯菌,40对大肠杆菌和假单胞菌具有优异的抗菌活性。化合物36、38和42对黄曲霉有抑制作用,化合物41对小孢子菌具有抑制作用,化合物42对Mucor有抑制作用,化合物39和40对根霉有抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号